Life Science Tools, MDx M&A Flat in 2011; Improvement Ahead? | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the genomics tools and molecular diagnostics markets in 2011 was flat compared to 2010 as a strong start to the year fizzled out in the second half.

Despite the late-year lull, some experts are predicting a rebound in M&A activity over the next couple of years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.